---
document_datetime: 2023-09-21 22:10:40
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/sibnayal-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: sibnayal-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 14.8519005
conversion_datetime: 2025-12-21 16:05:46.136734
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## SIBNAYAL

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                          | Opinion/ Notification 0F 1 issued on   | Commission Decision Issued 1F 2 / amended on   | Product Information affected 2F 3   | Summary                           |
|----------------------|------------------------------------------------------------------------------------------------|----------------------------------------|------------------------------------------------|-------------------------------------|-----------------------------------|
| IB/0009              | B.II.f.z - Stability of FP - Other variation                                                   | 27/06/2023                             |                                                | SmPC, Labelling and PL              |                                   |
| PSUSA/10932 /202210  | Periodic Safety Update EU Single assessment - potassium citrate / potassium hydrogen carbonate | 08/06/2023                             | n/a                                            |                                     | PRAC Recommendation - maintenance |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0008             | B.II.b.4.z - Change in the batch size (including batch size ranges) of the finished product - Other variation                                                                                                                                                                                                                                                                                           | 13/03/2023   | n/a        |                                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------------------------|
| IA/0006             | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                              | 12/12/2022   | n/a        |                                   |
| PSUSA/10932 /202204 | Periodic Safety Update EU Single assessment - potassium citrate / potassium hydrogen carbonate                                                                                                                                                                                                                                                                                                          | 01/12/2022   | n/a        | PRAC Recommendation - maintenance |
| PSUSA/10932 /202110 | Periodic Safety Update EU Single assessment - potassium citrate / potassium hydrogen carbonate                                                                                                                                                                                                                                                                                                          | 10/06/2022   | n/a        | PRAC Recommendation - maintenance |
| IAIN/0004           | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                              | 25/04/2022   | 24/03/2023 | SmPC, Labelling and PL            |
| II/0002/G           | This was an application for a group of variations. B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation B.II.b.3.b - Change in the manufacturing process of the finished or intermediate product - Substantial changes to a manufacturing process that may have a significant impact on the quality, safety and efficacy of the medicinal product | 10/02/2022   | n/a        |                                   |
| IA/0001             | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                            | 15/06/2021   | n/a        |                                   |

<div style=\"page-break-after: always\"></div>